Status:

UNKNOWN

Moxibustion Plus Cupping in Convalescent Patients With COVID-19

Lead Sponsor:

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Collaborating Sponsors:

Hubei Hospital of Traditional Chinese Medicine

Hubei Provincial Hospital of Integrated Chinese & Western Medicine

Conditions:

COVID-19

Convalescence

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

This trial is designed to evaluate the efficacy and safety of moxibustion plus cupping in the convalescence of COVID-19.

Detailed Description

Moxibustion plus cupping may be effective and safe for convalescent patients with COVID-19, but evidence is limited. The randomized clinical trial may help to provide evidence-based factors for improv...

Eligibility Criteria

Inclusion

  • Clinical diagnosis of the convalescence of COVID-19 (defined by the Chinese Guideline for COVID-19 in 2020 Trial Version 7).
  • 18-70 years old;
  • chest tightness/fatigue/shortness of breath/cough, with at least 2 of the above symptoms and the average VAS score (last 48 hours) ≥ 40 points;
  • Volunteers with informed consent;

Exclusion

  • Surgery in the lung that affects lung function;
  • Rely on mechanical ventilation to maintain lung function;
  • Chronic lung diseases affecting lung function;
  • Diseases affecting heart function;
  • Severe basic diseases;
  • Resting heart rate \> 120/min, systolic blood pressure \> 180mmHg, diastolic blood pressure \> 100mmHg;
  • Unstable angina or myocardial infarction in the past 1 month;
  • Severe obesity (BMI\>30kg/m2);
  • Allergic constitution;
  • Pregnant or lactating women;
  • Disabled patients;
  • Mentally ill Patients;
  • Participating in other clinical trials;
  • Poor compliance or other complicate conditions according to the researchers.

Key Trial Info

Start Date :

May 10 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2021

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04374084

Start Date

May 10 2020

End Date

December 1 2021

Last Update

November 24 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hubei Province Hospital

Wuhan, Hubei, China